Trio's pioneering silicone ostomy product wins prestigious Queen's Award for Enterprise

A life changing silicone adhesive that prevents abdominal stomas from leaking and provides a range of benefits for patients and healthcare professionals, has been awarded the prestigious Queen's Award for Enterprise.

Lloyd Pearce, Managing Director, Trio

Privately-owned Trio Healthcare was presented the award under the Innovation category for its breakthrough patented silicone technology, which is improving the lives of ostomates around the world. It is the UK’s most prestigious business accolade which recognizes the benefits offered to ostomates and their unique needs.

Abdominal stomas are surgically created intestinal openings which are a result of treating conditions such as colorectal and bladder cancer, Crohn’s or colitis. The stoma outputs body waste such as feces and urine which is then collected in an odor-proof bag. At one time or another, all ostomates will suffer from leakage and therefore damaged to the skin, which has a dramatic impact on their social life and psychological wellbeing.

To combat this, Trio has developed a unique, secure adhesive known as Trio Responsive® Silicone, that can be used around the stoma to provide a skin-friendly seal and a long awaited alternative solution to hydrocolloid. The company’s R&D team have focused on using a non-hydrocolloid technology to develop their innovation using silicone polymers.

By modifying the chemical make-up of the silicone formulation, Trio has developed a secure but comfortable solution that allows the skin to breathe normally, even perspire, whilst maintaining a secure connection. The patented formulation leaves no residue and its waterproof nature prevents absorption of any feces or urine providing a complete barrier, which allows the skin to naturally heal underneath.

The development of the pioneering technology – which is manufactured in house -has enabled Trio to launch a revolutionary range of silicone-based accessory products in an industry dominated by hydrocolloid. These products are seen as a precursor to the natural next phase of ostomy products coming out of Trio’s pipeline. The company is currently in the development phase of a new, innovative ostomy system to complete the range.

Lloyd Pearce, Managing Director from Trio, said:

We are delighted to win such a prestigious award for our contribution to ostomy care. Due to the stigma and embarrassment associated with body waste and bag leakage, a person’s social life and well-being is dependent on the ostomy adhesive and bag’s performance.

Too many people around the world were suffering from leakage and irritated skin, so as a company we have made it our mission to provide an alternative solution. Our products offer reassurance and comfort, so the wearer can get on with their everyday lives without fear of sore skin.

The Queen’s Awards are presented each year by Her Majesty Queen Elizabeth II on her birthday, 21st April, on the advice of the Prime Minister, assisted by an advisory committee comprising representatives of Government, industry, commerce and the trade unions. The company will attend a reception at Buckingham Palace in June, hosted by HRH Prince of Wales.

This is the second time Trio Healthcare have been the recipients of a Queen’s Award for Enterprise. In 2011 they were awarded the Queen’s Award - International Trade. The company have offices in both Buckinghamshire and North Yorkshire.

Source: http://trioostomycare.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows cannabis as a genotoxic substance with cancer risks